With [14C]testosterone as substrate, oestradiol stimulated the formation of DHT by 63% (n 6; P<0.01). The aim here was to hair loss study the effect of the anti-androgen finasteride on 5 alpha-reduction of androgens by human gingival fibroblasts (HGF) and its modulation by oestradiol-17 beta. Oestradiol-induced stimulation of 5 alpha-reductase activity on androgen substrates by HGF is suggestive of hormone modulatory mechanisms in the healing periodontium of both sexes. A genetic factor responsible for familial BPH may exert its influence through androgen hair loss independent control of prostatic growth. MATERIALS AND METHODS. There were 300-700% increases drug store hair loss in the formation of testosterone in response to F and O alone and in combination (n 6; P<0.01). Mean prostate volume in men with familial and sporadic BPH was 82.7 and 55.5 ml., respectively (p < 0.001).
Its inhibition by finasteride is suggestive of type 2 isoenzyme activity, confirming target-tissue functions in the gingiva.. Urinary flow rate, prostate size, finasteride drug symptom score, serum prostate specific antigen, testosterone and dihydrotestosterone were measured in subjects who participated in the nationwide Merck phase III finasteride clinical trial. Logistic regression was used to detect relationships between familial BPH, and these variables before and after 5 alpha-reductase inhibition with finasteride. Effects propecia price of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.5 alpha-Reduction of androgen substrates results in the formation of the biologically active androgen 5 alpha-dihydrotestosterone (DHT), while 17 beta-hydroxysteroid dehydrogenase metabolises androgen substrates to 4-androstenedione or testosterone. We attempted to determine the clinical and biological characteristics of familial benign prostatic hyperplasia (BPH). Familial BPH in this group of patients was associated with large prostate size, normal serum androgen levels and normal response to 5 alpha-reductase inhibition. The combination of O F produced 43% less inhibition than finasteride alone (n 6; P<0.01).
Other clinical findings, including serum androgen levels and response to finasteride, were similar in familial and sporadic BPH. Clinical and biological characteristics of familial benign prostatic hyperplasia.PURPOSE. Familial BPH was characterized by large prostate size. Duplicate cultures of HGF were incubated with [14C]testosterone/[14C]4-androstenedione in Eagle minimum essential medium (n 6) in the presence or absence of oestradiol-17 beta (O) or finasteride (F; 0.1-3 microg/ml) for 24 h. The mechanical wave of familial BPH in patients with prostate size in the largest and smallest deciles was 46 and 13%, respectively.
Findings in the 69 men with familial BPH (3 or more family members with BPH, including the proband) were compared to those in the 345 with no family history of BPH. The steroid metabolites were analysed and quantified using a radioisotope scanner. Oestradiol stimulated the formation of DHT from [14C]4-androstenedione by 300-600% and finasteride reduced the yield of DHT by 40-64%; there was less inhibition in combination with O. In contrast, finasteride inhibited this activity by 61% (n 6; P<0.01).
There were 200-300% increases in the formation of 4-androstenedione in response to O and F, being less pronounced in combination.
.